Esther Zamora Adelantado (Esther Zamora)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Atrial Fibrillation

Monoclonal Antibody

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora Adelantado, Fernando Moreno Antón, José Angel García-Saenz, Sonia Pernas, Noelia Martínez Jáñez, Desirée Jiménez, Encarna Adrover, R Andrés Conejero, Silvana Mourón, Maria Jose Bueno, Luis Manso Sanchez, Gemma Viñas, Emilio Alba, Antonio Llombart, Javier Cortes, Cristina Tebar, Denise J Roe, Adam Grant, Adam W Watson, Ramón Colomer, Ghassan Mouneimne
High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Nikaoly Ciriaco, Esther Zamora Adelantado, Santiago Escriva-de-Romani, Ignacio Miranda Gómez, Jose Jimenez, Cristina Saura, Hillary Sloane, Anna Starus, Johannes Fredebohm, Lucy Georgieva, Graham Speight, Frederick Jones, Santiago Ramón Y Cajal, Martín Espinosa-Bravo, Vicente Peg
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response. Therapeutic advances in medical oncology 14 (2022)
Sherko Kuemmel, Mario Campone, Delphine Loirat, Rafael Lopez Lopez, J Thaddeus Beck, Michelino De Laurentiis, Seock-Ah Im, Sung-Bae Kim, Ava Kwong, Guenther G Steger, Esther Zamora Adelantado, Fran Ois P Duhoux, Richard Greil, Irene Kuter, Yen-Shen Lu, Ariadna Tibau, Mustafa Özgüroğlu, Claus-Jürgen Scholz, Christian F Singer, Estela Vega, Pauline Wimberger, Claudio Zamagni, Xuan-Mai Couillebault, Liqiong Fan, Nelson Guerreiro, Jennifer Mataraza, Janna Sand-Dejmek, Arlene Chan
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)